licensing of technology to China (with reference to the chemical industry).
Read Online

licensing of technology to China (with reference to the chemical industry). by Christopher Ball

  • 316 Want to read
  • ·
  • 66 Currently reading

Published in Bradford .
Written in English

Book details:

Edition Notes

M.B.A. dissertation. Typescript.

ID Numbers
Open LibraryOL13979680M

Download licensing of technology to China (with reference to the chemical industry).


4 Ch. 1 Licensing and Technology Transfer to China: A Roadmap Among the countries most suspect in this regard is China. For several decades after the Communist Revolution of , China remained to a large extent out-side both the global trading economy and world intellectual property regimes. Technology licensing in China Yuandi Wang1, Jason Li-Ying2,*, Jin Chen3 and Zheng Lu4 1Business School of Sichuan University, Sichuan University, No. 29, Wangjiang Road, Chengdu, , Sichuan.   In general, the statistics show a positive trend in U.S. licensing of technology to China. However, these positive developments are counterbalanced by more restrictive U.S. export control sanctions affecting Chinese companies’ abilities to participate in standards setting, acquire U.S. technology and enter foreign markets.   Historically, China has allowed its citizens to connect to the global Internet subject to the use of a firewall to block content viewed as illegal or potentially harmful to the state.

  The usual China trademark license is for a 20 year term, but it can and does vary. Normally, the sole basis for terminating the licensing agreement is for the Chinese company failing to pay the license fee. It is possible to provide for a minimum annual royalty payment and falling short allows for early termination, but this is fairly unusual. information technology, retail, and financial services. China’s Administrative Licensing System and Challenges. As in any jurisdiction, companies need operating in China a number of licenses, permits, and may certifications to operate legally in the market—in some cases up to .   Current state of the book business. The book industry in China is controlled by the government, the State Administration for Press, Publications, Radio, Film, and TV. They control the copyrights, number of ISBNs distributed, imports, and all other book publisher rules. There are authorized book publishers in China, primarily based in Beijing. In the event the license agreement fails, foreign companies must remain prepared to protect their IP. Strong relationships, or guanxi, can go a long way in helping a foreign company combat the challenges of licensing technology in China. Sherif Ibrahim. References: Best Practices: Intellectual Property Protection in China (Rep.). ().

  For example, instead of licensing to a company in China, it may be possible to license to a Chinese company outside the PRC. The foreign entity could provide a written contract provision prohibiting import of the technology into China, but with the unwritten understanding that the licensor will not object to such import so long as the licensee.   To license technology successfully in China, the foreign party must understand local preferences. In general, Chinese companies prefer to own a technology rather than license a technologically advanced device or method. On the other hand, foreign business partners, cautious of China’s history of weak IP rights enforcement, have sought to. China was a world leader in science and technology until the early years of the Ming dynasty. Chinese discoveries and Chinese innovations such as papermaking, printing, the compass, and gunpowder (the Four Great Inventions) contributed to the economic development in East Asia, the Middle East and e scientific activity started to decline in the fourteenth century. Drug in-licensing opportunities are expected to increase steeply in the next few years as more Chinese pharmaceutical companies are transitioning into novel drug discovery and development. China in-licensing deals. Chinese companies are avoiding using traditional generics manufacturing and .